Press Room

As the U.S. Supreme Court prepares to hear oral arguments in the case Braidwood Management v. Kennedy on Monday, 33 organizations representing millions of patients with serious health conditions and thousands of health care professionals are urging the Court to protect access to lifesaving preventive care without patient cost-sharing.

Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments in a letter to the Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) opposing the 2025 Marketplace Integrity Proposed Rule.

This week, the U.S. House of Representatives is expected to vote on a budget resolution that could lead to devastating cuts to Medicaid.

Ahead of an expected vote on a budget resolution, ACS CAN is urging Senators to oppose legislation that would make cuts to Medicaid.

Today, the U.S. Supreme Court ruled unanimously that the Food and Drug Administration (FDA) followed the law in issuing marketing denial orders (MDOs) for certain flavored e-cigarette products.

Today, the U.S. Department of Health and Human Services (HHS) announced it will be cutting more than 10,000 jobs as part of a major restructuring that will impact operations at the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), among other critical agencies.

The U.S. House of Representatives introduced the Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2025. The legislation would reauthorize the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030.

Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).

Yesterday, the U.S. Senate voted to confirm Dr. Marty Makary as the next commissioner of the Food and Drug Administration (FDA).

In a new, large national study published today in the Journal of the American Medical Association (JAMA) Network Open, American Cancer Society (ACS) researchers found the 2018 federal policy loosening restrictions on STLD insurance plans was associated with an increase in late-stage cancer diagnoses in states without or with inadequate additional STLD plan regulatory protections.